Electrical Phrenic Nerve Stimulation in Patients With VIDD
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to examine efficacy of transcutaneous electrical phrenic nerve stimulation (TEPNS) in ventilator-induced diaphragmatic dysfunction (VIDD). The investigators recruit VIDD patients, and randomly assign the patients into TEPNS group and control group. TEPNS group receives TEPNS twice a day for consecutive 5 days. Control group only receives usual care. The investigators collect diaphragm function indicators and outcomes to evaluate the efficacy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 20, 2024
CompletedFirst Posted
Study publicly available on registry
May 31, 2024
CompletedStudy Start
First participant enrolled
June 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedNovember 12, 2024
June 1, 2024
1.5 years
May 20, 2024
November 10, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Transdiaphragmatic pressure (Pdi)
Pdi=gastric pressure - esophageal pressure
Collected once a day after transcutaneous electrical phrenic nerve stimulation (TEPNS) for consecutive 5 days
Secondary Outcomes (5)
Airway pressure, esophageal pressure, gastric pressure, airway occlusion pressure, driving pressure, transpulmonary pressure
Collected once a day after TEPNS for consecutive 5 days
Esophageal pressure-time product
Collected once a day after TEPNS for consecutive 5 days
Ventilation days
Collected at 28 days after enrollment
Length of ICU stay
Collected at 28 days after enrollment
28-day mortality
Collected at 28 days after enrollment
Study Arms (2)
transcutaneous electrical phrenic nerve stimulation (TEPNS) group
EXPERIMENTALThe patients in TEPNS group receive TEPNS and usual care.
Control group
NO INTERVENTIONThe patients in control group receive usual care only.
Interventions
TEPNS is conducted twice a day for consecutive 5 days. Electrodes are applied to bilateral neck skin which phrenic nerve runs underneath.
Eligibility Criteria
You may qualify if:
- aged ≥ 18 years
- ventilated for at least 48 h with an expected stay of more than 7 days in the ICU
- diaphragm thickening fraction (DTF)\< 25%
You may not qualify if:
- having a pacemaker
- cutaneous lesion that could interfere with probes
- previous diaphragmatic nerve paralysis
- body mass index \> 35 kg/m2
- severe chronic obstructive pulmonary disease (FEV1/FVC\<30%)
- pregnancy or lactation
- decision to withhold life-sustaining treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Third Hospital
Beijing, Beijing Municipality, 100191, China
Related Publications (6)
Bao Q, Chen L, Chen X, Li T, Xie C, Zou Z, Huang C, Zhi Y, He Z. The effects of external diaphragmatic pacing on diaphragm function and weaning outcomes of critically ill patients with mechanical ventilation: a prospective randomized study. Ann Transl Med. 2022 Oct;10(20):1100. doi: 10.21037/atm-22-4145.
PMID: 36388825BACKGROUNDMedrinal C, Machefert M, Lamia B, Bonnevie T, Gravier FE, Hilfiker R, Prieur G, Combret Y. Transcutaneous electrical diaphragmatic stimulation in mechanically ventilated patients: a randomised study. Crit Care. 2023 Aug 30;27(1):338. doi: 10.1186/s13054-023-04597-1.
PMID: 37649092BACKGROUNDO'Rourke J, Sotak M, Curley GF, Doolan A, Henlin T, Mullins G, Tyll T, Omlie W, Ranieri MV. Initial Assessment of the Percutaneous Electrical Phrenic Nerve Stimulation System in Patients on Mechanical Ventilation. Crit Care Med. 2020 May;48(5):e362-e370. doi: 10.1097/CCM.0000000000004256.
PMID: 32191413BACKGROUNDSotak M, Roubik K, Henlin T, Tyll T. Phrenic nerve stimulation prevents diaphragm atrophy in patients with respiratory failure on mechanical ventilation. BMC Pulm Med. 2021 Oct 8;21(1):314. doi: 10.1186/s12890-021-01677-2.
PMID: 34625059BACKGROUNDPoulard T, Bachasson D, Fosse Q, Nierat MC, Hogrel JY, Demoule A, Gennisson JL, Dres M. Poor Correlation between Diaphragm Thickening Fraction and Transdiaphragmatic Pressure in Mechanically Ventilated Patients and Healthy Subjects. Anesthesiology. 2022 Jan 1;136(1):162-175. doi: 10.1097/ALN.0000000000004042.
PMID: 34788380BACKGROUNDGoligher EC, Dres M, Patel BK, Sahetya SK, Beitler JR, Telias I, Yoshida T, Vaporidi K, Grieco DL, Schepens T, Grasselli G, Spadaro S, Dianti J, Amato M, Bellani G, Demoule A, Fan E, Ferguson ND, Georgopoulos D, Guerin C, Khemani RG, Laghi F, Mercat A, Mojoli F, Ottenheijm CAC, Jaber S, Heunks L, Mancebo J, Mauri T, Pesenti A, Brochard L. Lung- and Diaphragm-Protective Ventilation. Am J Respir Crit Care Med. 2020 Oct 1;202(7):950-961. doi: 10.1164/rccm.202003-0655CP.
PMID: 32516052BACKGROUND
Study Officials
- PRINCIPAL INVESTIGATOR
Zongyu Wang, Dr.
Peking University Third Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
May 20, 2024
First Posted
May 31, 2024
Study Start
June 4, 2024
Primary Completion
December 1, 2025
Study Completion
January 1, 2026
Last Updated
November 12, 2024
Record last verified: 2024-06